中国过敏性哮喘诊治指南(第一版,2019年)

2019-09-10 中华医学会呼吸病学分会哮喘学组 中华内科杂志.2019,58(9):636-654.

过敏性哮喘是支气管哮喘中的重要类型,占支气管哮喘的60%~80%。本指南分为十五个章节,从过敏性哮喘的流行病学、发病机制、常见过敏原、临床表现到诊断、治疗和预防原则进行了详细的介绍,突出了过敏性哮喘与非过敏性哮喘的异同,在国际和我国支气管哮喘指南基本原则的基础上,重点介绍了特异性免疫治疗、抗IgE治疗、抗过敏治疗、合并其他过敏性疾病的治疗及三级预防措施,根据循证医学证据和我国临床实践,提出了推荐意

中文标题:

中国过敏性哮喘诊治指南(第一版,2019年)

发布日期:

2019-09-10

简要介绍:

过敏性哮喘是支气管哮喘中的重要类型,占支气管哮喘的60%~80%。本指南分为十五个章节,从过敏性哮喘的流行病学、发病机制、常见过敏原、临床表现到诊断、治疗和预防原则进行了详细的介绍,突出了过敏性哮喘与非过敏性哮喘的异同,在国际和我国支气管哮喘指南基本原则的基础上,重点介绍了特异性免疫治疗、抗IgE治疗、抗过敏治疗、合并其他过敏性疾病的治疗及三级预防措施,根据循证医学证据和我国临床实践,提出了推荐意见,以指导我国过敏性哮喘的诊治与管理。

 

拓展指南:哮喘相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220083, encodeId=aa9f122008311, content=有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:21:30 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210470, encodeId=a19612104e027, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Tue Apr 12 08:57:34 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016274, encodeId=7a7f10162e4b6, content=来学习一下过敏性哮喘的治疗方案, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=068d5591096, createdName=ms6000001668113621, createdTime=Fri Sep 10 11:04:15 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014263, encodeId=5e8b1014263cd, content=学习一下变异型哮喘的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Sep 03 12:27:42 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975852, encodeId=ffc19e58527d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40432872128, createdName=xiaoxi443, createdTime=Tue Jun 22 17:24:06 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2022-05-16 ms1000001987466727

    有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220083, encodeId=aa9f122008311, content=有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:21:30 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210470, encodeId=a19612104e027, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Tue Apr 12 08:57:34 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016274, encodeId=7a7f10162e4b6, content=来学习一下过敏性哮喘的治疗方案, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=068d5591096, createdName=ms6000001668113621, createdTime=Fri Sep 10 11:04:15 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014263, encodeId=5e8b1014263cd, content=学习一下变异型哮喘的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Sep 03 12:27:42 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975852, encodeId=ffc19e58527d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40432872128, createdName=xiaoxi443, createdTime=Tue Jun 22 17:24:06 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2022-04-12 ms1000001656413688

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220083, encodeId=aa9f122008311, content=有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:21:30 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210470, encodeId=a19612104e027, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Tue Apr 12 08:57:34 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016274, encodeId=7a7f10162e4b6, content=来学习一下过敏性哮喘的治疗方案, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=068d5591096, createdName=ms6000001668113621, createdTime=Fri Sep 10 11:04:15 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014263, encodeId=5e8b1014263cd, content=学习一下变异型哮喘的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Sep 03 12:27:42 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975852, encodeId=ffc19e58527d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40432872128, createdName=xiaoxi443, createdTime=Tue Jun 22 17:24:06 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-09-10 ms6000001668113621

    来学习一下过敏性哮喘的治疗方案

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1220083, encodeId=aa9f122008311, content=有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:21:30 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210470, encodeId=a19612104e027, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Tue Apr 12 08:57:34 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016274, encodeId=7a7f10162e4b6, content=来学习一下过敏性哮喘的治疗方案, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=068d5591096, createdName=ms6000001668113621, createdTime=Fri Sep 10 11:04:15 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014263, encodeId=5e8b1014263cd, content=学习一下变异型哮喘的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Sep 03 12:27:42 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975852, encodeId=ffc19e58527d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40432872128, createdName=xiaoxi443, createdTime=Tue Jun 22 17:24:06 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-09-03 微探

    学习一下变异型哮喘的内容

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1220083, encodeId=aa9f122008311, content=有用 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:21:30 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210470, encodeId=a19612104e027, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Tue Apr 12 08:57:34 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016274, encodeId=7a7f10162e4b6, content=来学习一下过敏性哮喘的治疗方案, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=068d5591096, createdName=ms6000001668113621, createdTime=Fri Sep 10 11:04:15 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014263, encodeId=5e8b1014263cd, content=学习一下变异型哮喘的内容, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Sep 03 12:27:42 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975852, encodeId=ffc19e58527d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40432872128, createdName=xiaoxi443, createdTime=Tue Jun 22 17:24:06 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-06-22 xiaoxi443

    学习了

    0